2021年5期
刊物介紹
Hepatobiliary&Pancreatic Diseases International a journal published by First Affiliated Hospital,Zhejiang University School of Medicine,China. It p...Hepatobiliary&Pancreatic Diseases International a journal published by First Affiliated Hospital,Zhejiang University School of Medicine,China. It publishes peer-reviewed original papers,reviews and editorials econcerned with clinical practice and research in the fields of hepatobiliary and pancreatic cover the medical,surgical,radiological,pathological,biochemical,physiological and historical aspects of the subject areas under the headings Liver,Biliary,Pancreas,Transplantation,Research,Special Reports,Editorials,Review Articles,Brief Communications,Clinical Summary,Clinical Images and Case Reports. It also deals with the basic sciences and experimental work. The journal is abstracted adn indexed in SCI-E,IM/MEDLINE,EMBASE/EM,CA,Scopus,Science Direct,etc.更多簡介
Hepatobiliary & Pancreatic Diseases International
- Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study
- Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment
- Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study
- LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver
- Cryptococcosis in patients with liver cirrhosis: Death risk factors and predictive value of prognostic models
- Gene knockout or inhibition of macrophage migration inhibitory factor alleviates lipopolysaccharide-induced liver injury via inhibiting inflammatory response
- Efficacy and safety of conversion of percutaneous cholecystostomy to endoscopic transpapillary gallbladder stenting in high-risk surgical patients
- Pancreas sparing duodenectomy in the treatment of primary duodenal neoplasms and other situations with duodenal involvement
- Synergistic effects of anti-angiogenesis and immune checkpoint blockade -a new era of systemic chemotherapy for hepatocellular carcinoma
- Bioinformatics: A beacon of hope in identifying molecular target
- Intestinal microecology: A crucial strategy for targeted therapy of liver diseases
- Application of intraoperative ultrasound in liver surgery
- Delivery of genetic load during ex situ liver machine perfusion with potential for CRISPR-Cas9 gene editing: An innovative strategy for graft treatment
- Combination therapy of dabrafenib plus trametinib in patients with BRAF V600E -mutated biliary tract cancer
- Acute hepatitis associated with increased atypical lymphocyte
- MEETINGS AND COURSES
- EDITORS
- INFORMATION FOR READERS
- Hepatobiliary&Pancreatic Diseases International